Detlef Haase

12.1k total citations · 1 hit paper
101 papers, 3.1k citations indexed

About

Detlef Haase is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Detlef Haase has authored 101 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Hematology, 34 papers in Molecular Biology and 30 papers in Genetics. Recurrent topics in Detlef Haase's work include Acute Myeloid Leukemia Research (68 papers), Chronic Myeloid Leukemia Treatments (22 papers) and Acute Lymphoblastic Leukemia research (19 papers). Detlef Haase is often cited by papers focused on Acute Myeloid Leukemia Research (68 papers), Chronic Myeloid Leukemia Treatments (22 papers) and Acute Lymphoblastic Leukemia research (19 papers). Detlef Haase collaborates with scholars based in Germany, Austria and United States. Detlef Haase's co-authors include Christa Fonatsch, Julie Schanz, Aristoteles Giagounidis, Otto Krieger, Peter Valent, Reinhard Stauder, Michael Pfeilstöcker, Carlo Aul, Lorenz Trümper and Torsten Haferlach and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Detlef Haase

97 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

2007 540 citations Detlef Haase, Ulrich Germing et al. Blood profile →

Peers

Countries citing papers authored by Detlef Haase

Since Specialization

Citations

This map shows the geographic impact of Detlef Haase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Detlef Haase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Detlef Haase more than expected).

Fields of papers citing papers by Detlef Haase

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Detlef Haase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Detlef Haase. The network helps show where Detlef Haase may publish in the future.

Co-authorship network of co-authors of Detlef Haase

This figure shows the co-authorship network connecting the top 25 collaborators of Detlef Haase. A scholar is included among the top collaborators of Detlef Haase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Detlef Haase. Detlef Haase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real‐world cohort of patients with lower‐risk MDS 2024 ·HemaSphere ·(unknown), Christina Ganster, (unknown), Katayoon Shirneshan, (unknown), Elżbieta Brzuszkiewicz, Doris Steinemann, Maximilian Schieck, Catharina Müller‐Thomas, (unknown), Friederike Braulke, Ulrich Germing, Katja Sockel, Ekaterina Balaian, Julie Schanz, Uwe Platzbecker, Katharina S. Götze, Detlef Haase	1
2	VEXAS syndrome: complete molecular remission after hypomethylating therapy 2024 ·Annals of Hematology ·Katja Sockel, Katharina S. Götze, Christina Ganster, Marius Bill, (unknown), Ekaterina Balaian, Martin Aringer, Karolin Trautmann‐Grill, (unknown), Martin Bornhäuser, Detlef Haase, Christian Thiede	18
3	Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype 2023 ·SHILAP Revista de lepidopterología ·Mar Mallo, Heinz Tuechler, Leonor Arenillas, Sophie Raynaud, Thomas Cluzeau, Lee‐Yung Shih, (unknown), Christina Ganster, Katayoon Shirneshan, Detlef Haase, (unknown), Laura Palomo, José Cervera, Esperanza Such, Nicola Trim, Sally Jeffries, (unknown), Giovanni Marconi, Giovanni Martinelli, Françesc Solé	3
4	Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology 2022 ·Current Oncology ·Evgenii Shumilov, (unknown), Martin S. Zinkernagel, (unknown), Naomi Porret, (unknown), Detlef Haase, Georg Lenz, Urban Novak, Yara Banz, Thomas Pabst, Ulrike Bacher	3
5	Luspatercept Treatment Leads to Long Term Increases in Hemoglobin and Reductions in Transfusion Burden in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Preliminary Results from the Phase 2 PACE-MDS Extension Study 2015 ·Blood ·Aristoteles Giagounidis, Uwe Platzbecker, Ulrich Germing, Katharina S. Götze, Philipp Kiewe, Karin Mayer, Oliver G. Ottmann, Markus P. Radsak, Thomas Wolff, Detlef Haase, (unknown), Dawn Wilson, Xiaosha Zhang, (unknown), Matthew L. Sherman, Kenneth M. Attie	22
6	Influence of total genomic alteration and chromosomal fragmentation on response to a combination of azacitidine and lenalidomide in a cohort of patients with very high risk MDS 2015 ·Leukemia Research ·Christina Ganster, Katayoon Shirneshan, Gabriela Salinas-Riester, Friederike Braulke, Julie Schanz, Uwe Platzbecker, Detlef Haase	9
7	Metamizol Suicide - Lethal Outcome Despite Maximum Therapy 2012 ·Detlef Haase, (unknown), (unknown), (unknown), (unknown)	1
8	Use of Total and Unbound Imatinib and Metabolite LC-MS/MS Assay to Understand Individual Responses in CML and GIST Patients 2011 ·Therapeutic Drug Monitoring ·Frank Streit, Lutz Binder, (unknown), Gunnar Brandhorst, Friederike Braulke, Detlef Haase, Thomas Armbrust, Silke Cameron, Giuliano Ramadori, Michael Oellerich, Philip D. Walson	21
9	Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): Consensus statements and report from an expert workshop 2011 ·Leukemia Research ·Uwe Platzbecker, Valeria Santini, Ghulam J. Mufti, Claudia Haferlach, Jaroslaw P. Maciejewski, Sophie Park, Françesc Solé, Arjan A. van de Loosdrecht, Detlef Haase	14
10	Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group 2010 ·Annals of Hematology ·Katharina S. Götze, Uwe Platzbecker, Aristoteles Giagounidis, Detlef Haase, Michael Lübbert, Carlo Aul, Arnold Ganser, Ulrich Germing, Wolf‐Karsten Hofmann	30
11	FISH analysis of circulating CD34+ cells as a new tool for genetic monitoring in MDS: Verification of the method and application to 27 MDS patients 2010 ·Leukemia Research ·Friederike Braulke, Julie Schanz, Klaus Jung, Katayoon Shirneshan, (unknown), (unknown), (unknown), Lorenz Trümper, Detlef Haase	18
12	Solitary Cutaneous Nodule of Blastic Plasmacytoid Dendritic Cell Neoplasm Progressing to Overt Leukemia Cutis After Chemotherapy: Immunohistology and FISH Analysis Confirmed the Diagnosis 2009 ·American Journal of Dermatopathology ·Kjell M. Kaune, Mario Baumgart, Hans Peter Bertsch, Christina Mitteldorf, Hans Konrad Müller‐Hermelink, Detlef Haase, Β. Michael Ghadimi, Michael P. Schön, Christine Neumann	12
13	Amifostine has the potential to induce haematologic responses and decelerate disease progression in individual patients with low- and intermediate-1-risk myelodysplastic syndromes 2009 ·Leukemia Research ·Julie Schanz, Heike Jung, Bernhard Wörmann, W. Gaßmann, (unknown), Axel Hinke, Detlef Haase	6
14	Bullous Sweet Syndrome in a Patient With t(9;22)(q34;q11)-Positive Chronic Myeloid Leukemia Treated With the Tyrosine Kinase Inhibitor Nilotinib 2008 ·Archives of Dermatology ·Kjell M. Kaune, Mario Baumgart, Stefan Gesk, Christina Mitteldorf, (unknown), Bertram Glaß, Detlef Haase, Reiner Siebert, Β. Michael Ghadimi, Christine Neumann, Steffen Emmert	22
15	Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss‐of‐function mutations 2005 ·Genes Chromosomes and Cancer ·Stefan Fröhling, Richard F. Schlenk, Jürgen Krauter, Christian Thiede, Gerhard Ehninger, Detlef Haase, Lana Harder, (unknown), Claudia Scholl, Michael A. Caligiuri, Clara D. Bloomfield, Hartmut Döhner, Konstanze Döhner	24
16	A BCR–JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia 2005 ·Genes Chromosomes and Cancer ·Frank Griesinger, (unknown), (unknown), Martina Podleschny, (unknown), (unknown), Bernhard Wörmann, Detlef Haase, Stefan K. Bohlander	104
17	[Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results]. 2004 ·Medizinische Klinik - Intensivmedizin und Notfallmedizin ·Detlef Haase, Volker Hanf, Thomas Schulz	3
18	Effects of hexadecylphosphocholine on phosphatidylcholine and phosphatidylserine metabolism in human lymphoma cells 2002 ·PubMed ·Dinko Berkovic, (unknown), Detlef Haase, E. A. M. Fleer, Claudia R. Binder	8
19	Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients 2001 ·British Journal of Haematology ·Claudia Schoch, Torsten Haferlach, Detlef Haase, (unknown), Helmut Löffler, Brigitte Schlegelberger, Peter Staib, Maria Cristina Sauerland, Achim Heinecke, Thomas Büchner, Wolfgang Hiddemann, (unknown)	128
20	Genetic instability in myelodysplastic syndrome: detection of microsatellite instability and loss of heterozygosity in bone marrow samples with karyotype alterations 2000 ·British Journal of Haematology ·(unknown), Detlef Haase, Claudia Schoch, Wolfgang Hiddemann, Frauke Alves	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact